ストックスクリーナーアプリを入手
3.17
0.63%
-0.02
プレマーケット:
3.09
-0.08
-2.52%
Nyxoah Sa (NYXH) 最新ニュース
Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn
Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - GuruFocus
Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - MarketBeat
Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks
Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st
Publication relating to transparency notifications - GlobeNewswire
Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com
NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada
Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat
Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView
NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Q4 Earnings Call Highlights - MarketBeat
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks
Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 富途牛牛
Nyxoah SA (NYXH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
What is the long term forecast for Nyxoah SA stockWeekly Trade Summary & AI Driven Stock Movement Reports - baoquankhu1.vn
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result - GuruFocus
Nyxoah SA expected to post a loss of 53 cents a shareEarnings Preview - TradingView
Earnings Preview: Nyxoah SA to Report Financial Results on March 19 - 富途牛牛
Publication relating to transparency notification - GlobeNewswire
Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewswire
Trading Recap: Will Nyxoah SA benefit from rising consumer demandShare Buyback & Target Return Focused Picks - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn
Technical Analysis: Does Nyxoah SA have a competitive edgeJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Aug Ideas: Can Nyxoah SA sustain its profitabilityPortfolio Growth Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - The Manila Times
Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat
Nyxoah (NYXH) Expected to Announce Earnings on Thursday - MarketBeat
Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat
Trading the Move, Not the Narrative: (NYXH) Edition - Stock Traders Daily
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Information on the total number of voting rights and shares - GlobeNewswire
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Macro Review: Can Nyxoah SA expand into new marketsJuly 2025 Update & High Accuracy Investment Signals - baoquankhu1.vn
How The Nyxoah (ENXTBR:NYXH) Story Is Shifting As Assumptions And Risks Are Reworked - Yahoo Finance
What’s Nyxoah SA’s historical returnQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
Healthcare Triangle and Nyxoah Compared in Financial Review - National Today
EV Market: Is Nyxoah SA forming bullish engulfing patternsIPO Watch & Weekly Chart Analysis and Guides - baoquankhu1.vn
Nyxoah SA (NYXH) Stock Analysis: Unveiling a 126% Potential Upside in Sleep Apnea Solutions - DirectorsTalk Interviews
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - The Manila Times
0.95%
0.04%
大文字化:
|
ボリューム (24 時間):